Page last updated: 2024-12-08

menthyl chloroformate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

menthyl chloroformate: RN given refers to (1R-(1alpha,2beta,5alpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151928
SCHEMBL ID160207
MeSH IDM0165918

Synonyms (26)

Synonym
menthyl chloroformate
AKOS015848628
(5-methyl-2-propan-2-ylcyclohexyl) carbonochloridate
carbonochloridic acid (5-methyl-2-propan-2-ylcyclohexyl) ester
(5-methyl-2-propan-2-yl-cyclohexyl) carbonochloridate
A808441
carbonochloridic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1r-(1alpha,2beta,5alpha))-
s(-)-menthyl chloroformate
FT-0604527
FT-0604427
50277-59-3
(-)menthyl chloroformate
menthyloxycarbonyl chloride
(+) menthyl chloroformate
(-)-menthylchloroformate
SCHEMBL160207
chloroformic acid p-menthan-3-yl ester
2-isopropyl-5-methylcyclohexyl carbonochloridate
DTXSID60932752
5-methyl-2-(propan-2-yl)cyclohexyl carbonochloridate
2-isopropyl-5-methylcyclohexylcarbonochloridate
AMY39901
A923722
SY101158
5-methyl-2-(propan-2-yl)cyclohexyl chloroformate
EN300-297827

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"Solvent extractive two-phase menthoxycarbonyl (MnOC) derivatization was combined with trimethylsilyl (TMS) reaction for enantioseparation of beta-blockers by gas chromatography employing achiral DB-5 and DB-17 dual-columns of different polarity."( N-Menthoxycarbonylation combined with trimethylsilylation for enantioseparation of beta-blockers by achiral dual-column gas chromatography.
Kim, KR; Nguyen, DT; Paik, MJ, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's6 (50.00)18.2507
2000's2 (16.67)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.64 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index27.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]